Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

BIOCHEMICAL DIAGNOSTICS INC

United States·US-MF-000025179

Last updated May 24, 2026

What BIOCHEMICAL DIAGNOSTICS INC makes

The company produces in vitro diagnostic (IVD) controls and reagents for detecting drugs of abuse in urine samples, including multi-panel tests for various substances. It also manufactures controls for ethanol (ETOH) testing and kits for measuring 17-hydroxycorticoid levels via spectrophotometry, alongside urine analyte controls and a human chorionic gonadotropin beta-core fragment test. Additional offerings include pregnancy screening tests and a device for monitoring vital signs.

These products fall under Class I and In Vitro Diagnostic (IVD) General device classifications, with regulatory listings in the EU’s EUDAMED database, the FDA’s 510(k) premarket notification process, and the FDA’s Unique Device Identifier (UDI) system. The manufacturer operates from the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Biochemical Diagnostics Inc manufacture?

Biochemical Diagnostics Inc specializes in in vitro diagnostic (IVD) products, primarily controls and reagents for detecting drugs of abuse in urine samples. Their portfolio includes multi-panel tests for various substances, ethanol (ETOH) controls, and kits for measuring 17-hydroxycorticoid levels using spectrophotometry. They also produce controls for urine analyte testing, a human chorionic gonadotropin beta-core fragment test, pregnancy screening devices, and a vital sign monitoring device. These products are designed for laboratory and point-of-care use.

Where is Biochemical Diagnostics Inc based, and what does that mean for regulatory oversight?

Biochemical Diagnostics Inc is based in the United States. Since the company operates in the U.S., its devices are subject to FDA regulations, including premarket notification (510(k)) requirements for Class I devices and compliance with the FDA’s Unique Device Identifier (UDI) system. The company’s products are also listed in the EU’s EUDAMED database, indicating they may be marketed or used in the European Union under applicable IVD regulations, though this does not imply EU approval.

How are the devices manufactured by Biochemical Diagnostics Inc classified under regulatory frameworks?

The devices produced by Biochemical Diagnostics Inc fall under Class I classification and In Vitro Diagnostic (IVD) General categories. Class I devices are typically considered low-risk, often requiring general controls like labeling and manufacturing practices, while IVD General classifications apply to diagnostic tests that do not pose significant health risks. This classification helps determine the regulatory pathway, such as FDA’s 510(k) process for Class I devices, ensuring compliance without stringent pre-market approval.

Which regulatory registries list the devices made by Biochemical Diagnostics Inc?

The devices manufactured by Biochemical Diagnostics Inc are listed in three key regulatory registries: EUDAMED, the European database for medical devices; the FDA’s 510(k) premarket notification database, which tracks Class I device submissions in the U.S.; and the FDA’s Unique Device Identifier (UDI) system, ensuring traceability and compliance tracking. These listings reflect the company’s adherence to regulatory requirements in both the U.S. and EU markets, though they do not confirm individual device approvals.

Why do some of the company’s devices appear under multiple names (e.g., Detectabuse vs. DETECTABUSE)?

The variations in naming conventions (e.g., *Detectabuse* vs. *DETECTABUSE*) likely reflect differences in branding, case sensitivity in labeling, or regional marketing preferences. Some devices may also appear under multiple names due to updates, rebranding, or variations in product lines (e.g., controls vs. kits). These discrepancies do not affect regulatory classification or compliance but may appear in databases or documentation depending on how the manufacturer registers or lists the device. Always refer to the official labeling or regulatory submissions for precise identification.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
United States
Address
180, Heartland Blvd, Edgewood, United States
LinkedIn
—
Facebook
—
Phone
6315959200
PRRC Contact
Amy Walsh
EUDAMED SRN
US-MF-000025179
FDA FEI Number
—
DUNS Number
028007698

Catalogue (484)

Page 1 of 10
DeviceModel / ReferenceRegistriesClassStatus
Salivabuse Custom QC29
FDA UDI
Class IUnknown
Detectabuse 18400051
FDA UDI
Class IUnknown
Detectabuse 18003215
FDA UDI
Class IActive
Detectabuse 702040
FDA UDI
Class IActive
Steroid-Skreen 35066608
FDA UDI
Class IUnknown
Detectabuse 18008449
FDA UDI
Class IActive
Steroid-Skreen 35066659
FDA UDI
Class IUnknown
Detectabuse 18003102
FDA UDI
Class IActive
Steroid-Skreen 35064214
FDA UDI
Class IUnknown
Life Sign 21000
FDA UDI
Class IActive
Detectabuse 18008421
FDA UDI
Class IActive
Detectabuse 19481370
FDA UDI
Class IActive
Detectabuse 88001
FDA UDI
Class IUnknown
Detectabuse 18008613
FDA UDI
Class IActive
Detectabuse 18007862
FDA UDI
Class IActive
Pregnancy-Skreen 18000442
FDA UDI
Class IActive
Detectabuse 18007525
FDA UDI
Class IActive
Steroid-Skreen 35066422
FDA UDI
Class IUnknown
Salivabuse Custom QC12
FDA UDI
Class IUnknown
Detectabuse 18002144
FDA UDI
Class IActive
Detectabuse 18008247
FDA UDI
Class IActive
Detectabuse 18008470
FDA UDI
Class IActive
Detectabuse 19555756
FDA UDI
Class IActive
Steroid-Skreen 35063307
FDA UDI
Class IUnknown
Detectabuse 18401099
FDA UDI
Class IActive
Detectabuse 18007978
FDA UDI
Class IActive
Premier PQ-22H-01
FDA UDI
Class IActive
Life Sign 21000
FDA UDI
Class IActive
Detectabuse 18008793
FDA UDI
Class IActive
Detectabuse 18008418
FDA UDI
Class IActive
Detectabuse 18008420
FDA UDI
Class IActive
Detectabuse 18008474
FDA UDI
Class IActive
Detectabuse 18008255
FDA UDI
Class IUnknown
Salivabuse 20200001
FDA UDI
Class IUnknown
Salivabuse 18100184
FDA UDI
Class IActive
Vma-Skreen 35071059
FDA UDI
Class IUnknown
Steroid-Skreen 35061703
FDA UDI
Class IUnknown
Detectabuse 18008332
FDA UDI
Class IActive
Detectabuse 18002951
FDA UDI
Class IActive
Steroid-Skreen 35064222
FDA UDI
Class IUnknown
Steroid-Skreen 35066233
FDA UDI
Class IUnknown
Detectabuse 18008510
FDA UDI
Class IActive
Detectabuse 18000707
FDA UDI
Class IActive
Detectabuse 18003225
FDA UDI
Class IActive
Vma-Skreen 35071806
FDA UDI
Class IUnknown
Detectabuse 18007536
FDA UDI
Class IActive
Express Check 18001129
FDA UDI
Class IActive
Detectabuse 18008792
FDA UDI
Class IActive
Detectabuse 18401100
FDA UDI
Class IActive
Detectabuse 18008463
FDA UDI
Class IActive

Related Companies

Authorised Representatives

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (1)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

Biochemical Diagnostics Inc. has one recall record initiated on 2015-09-14, which is marked as terminated. The recall pertains to CONSULT diagnostics hCG Controls, where discrepancies were noted between the storage temperatures listed on the kit labels and those on the individual vial labels and the package insert.

AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.

DateRecall No.ClassStatusReason
Sep 14, 2015Z-0328-2016—terminated

CONSULT diagnostics hCG Controls have discrepant storage temperatures listed on the kit labels when compared with the individual vial labels and the package insert.